PortalPublikationenAge-adjusted incidence, mortality, and survival rates of sta...

Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.

Standard

Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. / Sun, Maxine; Thuret, Rodolphe; Abdollah, Firas; Lughezzani, Giovanni; Schmitges, Jan; Tian, Zhe; Shariat, Shahrokh F; Montorsi, Francesco; Patard, Jean-Jacques; Perrotte, Paul; Karakiewicz, Pierre I.

in: EUR UROL, Jahrgang 59, Nr. 1, 1, 2011, S. 135-141.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Sun, M, Thuret, R, Abdollah, F, Lughezzani, G, Schmitges, J, Tian, Z, Shariat, SF, Montorsi, F, Patard, J-J, Perrotte, P & Karakiewicz, PI 2011, 'Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.', EUR UROL, Jg. 59, Nr. 1, 1, S. 135-141. <http://www.ncbi.nlm.nih.gov/pubmed/21035250?dopt=Citation>

APA

Sun, M., Thuret, R., Abdollah, F., Lughezzani, G., Schmitges, J., Tian, Z., Shariat, S. F., Montorsi, F., Patard, J-J., Perrotte, P., & Karakiewicz, P. I. (2011). Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. EUR UROL, 59(1), 135-141. [1]. http://www.ncbi.nlm.nih.gov/pubmed/21035250?dopt=Citation

Vancouver

Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. EUR UROL. 2011;59(1):135-141. 1.

Bibtex

@article{5af3c1d0f01c418dbd4f039bc5920f6c,
title = "Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.",
abstract = "The rising incidence of renal cell carcinoma (RCC) has been largely attributed to the increasing use of imaging procedures.",
keywords = "Humans, Male, Female, Age Factors, Prognosis, Survival Analysis, Survival Rate, Time Factors, Incidence, Age Distribution, Neoplasm Staging, Linear Models, SEER Program, North America/epidemiology, Carcinoma, Renal Cell/*epidemiology/mortality/pathology, Kidney Neoplasms/*epidemiology/mortality/pathology, Humans, Male, Female, Age Factors, Prognosis, Survival Analysis, Survival Rate, Time Factors, Incidence, Age Distribution, Neoplasm Staging, Linear Models, SEER Program, North America/epidemiology, Carcinoma, Renal Cell/*epidemiology/mortality/pathology, Kidney Neoplasms/*epidemiology/mortality/pathology",
author = "Maxine Sun and Rodolphe Thuret and Firas Abdollah and Giovanni Lughezzani and Jan Schmitges and Zhe Tian and Shariat, {Shahrokh F} and Francesco Montorsi and Jean-Jacques Patard and Paul Perrotte and Karakiewicz, {Pierre I}",
year = "2011",
language = "English",
volume = "59",
pages = "135--141",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.

AU - Sun, Maxine

AU - Thuret, Rodolphe

AU - Abdollah, Firas

AU - Lughezzani, Giovanni

AU - Schmitges, Jan

AU - Tian, Zhe

AU - Shariat, Shahrokh F

AU - Montorsi, Francesco

AU - Patard, Jean-Jacques

AU - Perrotte, Paul

AU - Karakiewicz, Pierre I

PY - 2011

Y1 - 2011

N2 - The rising incidence of renal cell carcinoma (RCC) has been largely attributed to the increasing use of imaging procedures.

AB - The rising incidence of renal cell carcinoma (RCC) has been largely attributed to the increasing use of imaging procedures.

KW - Humans

KW - Male

KW - Female

KW - Age Factors

KW - Prognosis

KW - Survival Analysis

KW - Survival Rate

KW - Time Factors

KW - Incidence

KW - Age Distribution

KW - Neoplasm Staging

KW - Linear Models

KW - SEER Program

KW - North America/epidemiology

KW - Carcinoma, Renal Cell/epidemiology/mortality/pathology

KW - Kidney Neoplasms/epidemiology/mortality/pathology

KW - Humans

KW - Male

KW - Female

KW - Age Factors

KW - Prognosis

KW - Survival Analysis

KW - Survival Rate

KW - Time Factors

KW - Incidence

KW - Age Distribution

KW - Neoplasm Staging

KW - Linear Models

KW - SEER Program

KW - North America/epidemiology

KW - Carcinoma, Renal Cell/epidemiology/mortality/pathology

KW - Kidney Neoplasms/epidemiology/mortality/pathology

M3 - SCORING: Journal article

VL - 59

SP - 135

EP - 141

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 1

M1 - 1

ER -